Visakhapatnam: As part of its groundbreaking initiative that aims to combat lung cancer, Apollo Cancer Centres (ACCs) ...

EMA granted clearance to advance belrestotug 400mg + dostarlimab as recommended Phase 3 dose and activate GALAXIES Lung-301 clinical sites in the EU- Interim data from inupadenant Phase 2 A2A-005 in ...

Divya Gupta, MD, assistant professor at Feinberg School of Medicine at Northwestern University, discussed the potential of using circulating tumor DNA and minimal residual disease (MRD) assays for ...

November is Lung Cancer Awareness Month — coinciding with the start of open enrollment for Affordable Care Act (ACA) ...

Cancer continues to be one of the most challenging diseases to treat worldwide. The three main methods used to treat cancer are surgical excision, chemotherapy, and radiation therapy. Immunotherapy ...

Akeso, Inc. (HK:9926) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At ...

Zai Lab Limited (ZLAB) announced the inclusion of AUGTYRO (repotrectinib) in China's National Reimbursement Drug List for ROS1+ ...

Many people know the common signs of the potentially deadly cancer include a cough and feeling breathless but a doctor has ...

The EC considered the treatment's activity in patients with advanced, PD-L1-positive esophageal and gastric cancers in the RATIONALE-305 and -306 trials.

US-based immuno-oncology company Aulos Bioscience has announced the first patients have been dosed as part of a trial ...

Stanford University medical professor Dr. Bryant Lin was diagnosed with stage IV lung cancer despite never smoking. Now, he's ...

Accompanying these findings is a call for refined treatment strategies that have potential to better outcomes among patients ...